| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/09/1998 | EP0512050B1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 09/09/1998 | EP0485392B1 Androgen derivatives for use in the inhibition of sex steroid activity |
| 09/09/1998 | EP0478732B1 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/09/1998 | EP0383759B1 N6 substituted 9-methyladenines: a new class of adenosine receptor antagonists |
| 09/09/1998 | CN1192781A Use of neuro-derived fetal cell lines for tranplantation therapy |
| 09/09/1998 | CN1192750A Cyclosporin derivatives with anti-HIV effect |
| 09/09/1998 | CN1192740A Novel camptothecin analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same |
| 09/09/1998 | CN1192739A N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 09/09/1998 | CN1192733A Stable reagent for prepn. of radiopharmaceuticals |
| 09/09/1998 | CN1192732A CB2 receptor agonist compounds |
| 09/09/1998 | CN1192729A Benzamide derivatives and their use as vasopressin antagonists |
| 09/09/1998 | CN1192697A Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 09/09/1998 | CN1192696A Spironolactone and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 09/09/1998 | CN1192692A Inhibin compositions and method of enhancing production performance |
| 09/09/1998 | CN1192690A Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 09/09/1998 | CN1192688A Treatment of HIV and other viral infections using combinatory therapy |
| 09/09/1998 | CN1192687A Bacterial inhibition with an oligosaccharide compound |
| 09/09/1998 | CN1192686A Method of treatment for lung diseases using antisense oligonucleotides |
| 09/09/1998 | CN1192685A Use of alendronate for preventing osteoporosis |
| 09/09/1998 | CN1192684A Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 09/09/1998 | CN1192683A Method for reducing amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus |
| 09/09/1998 | CN1192682A Compositions for use against parasitic protozoa |
| 09/09/1998 | CN1192681A Novel medical use |
| 09/09/1998 | CN1192680A Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions |
| 09/09/1998 | CN1192679A Compounds active at a novel side on receptor-operated calcium channel useful for treatment of neurological disorders |
| 09/09/1998 | CN1192678A Biological agent compositions |
| 09/09/1998 | CN1192654A Novel embolizing compositions |
| 09/09/1998 | CN1192651A Compositions for combatting ectoparasites |
| 09/09/1998 | CN1192473A Nucleic acid construct for expressing active substances which can be activated by proteases, and prepn. and use |
| 09/09/1998 | CN1192440A The intermediates diaza or oxadiazabicyclic compounds |
| 09/09/1998 | CN1192439A 2-amino-9-(3-hydroxymethyl-4-alkoxycarbonyloxybut-1-yl) purine and pharmaceutical composition containing same |
| 09/09/1998 | CN1192436A New-benzylpiperazine compounds, process for their prepn. and pharmaceutical compositions which contain them |
| 09/09/1998 | CN1192358A 聚维酮碘膜剂 Povidone iodine agent |
| 09/09/1998 | CN1192357A New use of caffeic acid and ferulic acid antagonistic endotheliolysin biological effect |
| 09/09/1998 | CN1039717C Method for preparing physostigmine carbamate derivatives |
| 09/09/1998 | CN1039714C Substituted indole derivatives, prepn. method and application thereof |
| 09/09/1998 | CN1039708C Method for prepn. of diiodo-compound |
| 09/09/1998 | CN1039673C Cytarabine ocfosfate hard capsule |
| 09/09/1998 | CN1039672C Quick-drying gel-type disinfectant for hands and fingers |
| 09/08/1998 | USRE35893 Dry, uniform, free-flowing granular combination of water soluble carbohydrate-based agglomerate and liquid nonaqueous antifoaming or defoaming composition of hydrocarbon, mineral or silicone oil containing silica |
| 09/08/1998 | US5804686 fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
| 09/08/1998 | US5804602 N-acetylated alpha-linked acidic dipeptidase inhibitors |
| 09/08/1998 | US5804599 Oxabicyclo(4.1.0)heptane derivatives; antibacterial agents |
| 09/08/1998 | US5804597 Agent for the prevention or treatment of cataracts |
| 09/08/1998 | US5804596 Administration; preferential incorporation of nutrients to lean body mass, not adipose tissue |
| 09/08/1998 | US5804593 For treatment of connective tissue degradation, osteo-, rheumatoid-, and septic arthritis; osteopenias, osteoporosis, corneal ulceration, peridontal disease, gastric ulcers. |
| 09/08/1998 | US5804592 Method for improving disturbed behavior and elevating mood in humans |
| 09/08/1998 | US5804590 Treatment and prophylaxis of osteoporosis |
| 09/08/1998 | US5804589 Treatment of pain; irritable bowel syndrome |
| 09/08/1998 | US5804588 Quinoline carboxanides and their therapeutic use |
| 09/08/1998 | US5804586 Therapeutic agents |
| 09/08/1998 | US5804585 Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
| 09/08/1998 | US5804584 Useful in treating individuals having a disease or treatment-induced toxicity, mediated by second messenger activity |
| 09/08/1998 | US5804582 Administering immunogenic organic amine salt of n,n'-diacetylcystine |
| 09/08/1998 | US5804581 Inhibition of matrix metalloproteases by substituted phenalkyl compounds |
| 09/08/1998 | US5804580 Benzoxazine derivatives, methods for obtaining same, and their use as drugs |
| 09/08/1998 | US5804577 Cephalosporin derivatives |
| 09/08/1998 | US5804573 With additive antioxidant, polyoxyalkyl stabilizer, carrier |
| 09/08/1998 | US5804572 Compositions for regulating skin wrinkles and/or skin atrophy |
| 09/08/1998 | US5804571 Administering an s-omega(omega-aminoalkylamino)alkyl dihydrogen phosphorothioate |
| 09/08/1998 | US5804570 Administering 4-amino-1-hydroxy-butylidene-1,1-bisphosphonate (alendronate) or salt to osteoporotic female |
| 09/08/1998 | US5804569 Exocylic-phosphoethanolamines |
| 09/08/1998 | US5804566 Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
| 09/08/1998 | US5804565 Antibiotic effective against haemophilus influenzae |
| 09/08/1998 | US5804562 Treatment of hypercholesterolemia or atherosclerosis |
| 09/08/1998 | US5804560 Modulates processing of amyloid precursor protein |
| 09/08/1998 | US5804559 Prodrug derivatives of enzyme inhibitors having hydroxyl groups, a process for preparing them, and their use |
| 09/08/1998 | US5804549 Glycerol monolaurate, nisin in the absence of a chelator and a carrier |
| 09/08/1998 | US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase |
| 09/08/1998 | US5804381 Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof |
| 09/08/1998 | US5804376 Nucleotide and amino acid sequences; expression vector; genetically engineered host cells; diagnostic tests |
| 09/08/1998 | US5804214 Nonsteroidal antiinflammatory agents, analgesics |
| 09/08/1998 | US5804210 Administering orally or parenterally animal safe amount of dibasic calcium phosphate or calcium carbonate and conjugated linoleic acid isomers to enhance calcium content of bone in the animal |
| 09/08/1998 | US5804209 Bioadhesive starches and process for their preparation |
| 09/08/1998 | US5804204 Potassium salts for treatment of hypertension |
| 09/08/1998 | US5804203 Topical product formulations containing strontium for reducing skin irritation |
| 09/08/1998 | US5804201 Immunomodulatory peptides of vespid antigen 5 |
| 09/08/1998 | US5804197 Recombinant canine herpesviruses |
| 09/08/1998 | US5804192 Process for obtaining procyanidol oligomers from plants by extractions |
| 09/08/1998 | US5804168 Pharmaceutical compositions and methods for protecting and treating sun damaged skin |
| 09/08/1998 | CA2083475C Derivatives of ethanolamine, their preparation, and the pharmaceutical compositions containing them |
| 09/07/1998 | CA2202345A1 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cox-2 |
| 09/05/1998 | CA2230965A1 New benzoxazinedione derivatives, a method of producing them and the use thereof |
| 09/04/1998 | CA2219095A1 Anhydrovinblastine for the treatment of cervical and lung cancer |
| 09/04/1998 | CA2205314A1 Anhydrovinblastine for the treatment of cervical and lung cancer |
| 09/04/1998 | CA2199065A1 Anhydrovinblastine for the treatment of cancer |
| 09/03/1998 | WO1998038513A1 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 09/03/1998 | WO1998038317A1 Factor x analogues with a modified protease cleavage site |
| 09/03/1998 | WO1998038207A1 Compositions for treating or preventing prostatic cancer |
| 09/03/1998 | WO1998038204A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/03/1998 | WO1998038199A1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 09/03/1998 | WO1998038198A1 Saponarin derivatives |
| 09/03/1998 | WO1998038194A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 09/03/1998 | WO1998038193A1 Method for the preparation of (+)-calanolide a and analogues thereof |
| 09/03/1998 | WO1998038189A1 Oxazolidines as 5-ht2a-antagonists |
| 09/03/1998 | WO1998038187A1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
| 09/03/1998 | WO1998038186A1 Quinoxalinediones |
| 09/03/1998 | WO1998038179A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | WO1998038178A1 Tripeptide and tetrapeptide pharmaceutical compounds |
| 09/03/1998 | WO1998038177A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING β-AMYLOID PEPTIDE |